Timber Pharmaceuticals TMBR
$ 0.34
0.0%
Quarterly report 2023-Q2
added 08-21-2023
Timber Pharmaceuticals Financial Statements 2011-2024 | TMBR
Annual Financial Statements Timber Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.43 M | 231 K | 49.2 K | 2.87 B | 3.39 B | 2.47 B | 4.01 B | - | 1.32 T | - | - | - |
Shares |
2.11 M | 809 K | 27.3 K | 644 K | 286 K | 119 K | 59.8 K | - | 10.2 M | - | - | - |
Historical Prices |
2.1 | 0.285 | 1.8 | 4.37 | 31.8 | 76.5 | 138 | 465 | 867 | - | - | - |
Net Income |
-19.4 M | -10.6 M | -9.69 M | -17.3 M | -16.6 M | -18.4 M | -15.6 M | - | -7.81 M | -52.3 K | - | - |
Revenue |
83.2 K | 887 K | - | 57 K | 73 K | 100 K | 64 K | - | 40 K | - | - | - |
Cost of Revenue |
- | - | - | 83 K | 250 K | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | -26 K | -177 K | -416 K | -173 K | - | 40 K | - | - | - |
Operating Income |
-19.2 M | -10.7 M | -20.2 M | -3.04 M | -16.9 M | -18.4 M | -15.2 M | - | -7.77 M | -1.51 M | -28 K | -59.1 K |
Interest Expense |
- | - | - | -778 K | -126 K | 145 K | -436 K | - | 76 K | 74 K | 5 K | - |
EBITDA |
-19.2 M | -10.6 M | -20.2 M | -16.4 M | -16.8 M | -18.2 M | -15.1 M | - | -7.75 M | -52.1 K | - | - |
Operating Expenses |
19.3 M | 11.5 M | 9.69 M | 16.5 M | 16.7 M | 18 M | 15 M | - | 7.77 M | 52.3 K | - | - |
General and Administrative Expenses |
6.02 M | 5.39 M | 4.28 M | 5.24 M | 5.14 M | 4.65 M | 4.17 M | - | 654 K | 1.2 K | - | - |
All numbers in USD currency
Quarterly Income Statement Timber Pharmaceuticals
2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
3.08 M | 3.08 M | 2.97 M | 2.1 M | 1.27 M | 1.27 M | 1.27 M | 733 K | 733 K | 35.1 M | 27.1 M | 18.9 M | 11.2 M | 1.5 M | - | 6.3 M | 6.3 M | 786 K | 160 M | 191 M | 7.65 M | 7.19 M | 67.7 M | 79.7 M | 74.4 M | 67.7 M | 25.2 M | 31.3 M | 28.7 M | 26.2 M | - | 21 M | 15.4 M | 11.7 M | 11.4 M | 10.9 M | 10.6 M | 9.35 M | 7.02 M | 7.02 M | 7.4 M | 7.38 B | 7.4 M | - | - | - | - | - | - | - |
Net Income |
-4.06 M | -4.06 M | - | -3.19 M | -9.5 M | -3.07 M | - | -3.01 M | -3.01 M | -1.87 M | - | 2.84 M | -15.2 M | -2.01 M | - | -577 K | -3.04 M | -3.62 M | - | -4.39 M | -4.41 M | -4.4 M | - | -3.71 M | -3.74 M | -5.4 M | - | -3.88 M | -5.03 M | -4.46 M | - | -3.85 M | -3.57 M | -3.62 M | - | -2.17 M | -1.78 M | -1.34 M | - | -451 K | -260 K | -109 K | -2.78 K | -8.16 K | -1.55 K | -95.4 K | -7 K | -5.94 K | -1.07 K | -1.3 K |
Revenue |
- | - | - | 83.2 K | 83.2 K | 83.2 K | - | 267 K | 389 K | 40.7 K | - | 325 K | 26.9 K | 26.9 K | - | 218 K | - | - | - | 10 K | 24 K | 18 K | - | 18 K | 17 K | 19 K | - | 33 K | 19 K | 33 K | - | 20 K | 5 K | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 60 K | 13 K | 7 K | - | 8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -50 K | 11 K | 11 K | - | 10 K | 8 K | 8 K | - | 5 K | 2 K | 13 K | - | 1 K | -5 K | -5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4 M | -4 M | - | -3.13 M | -9.4 M | -3.14 M | - | -3 M | -2.97 M | -1.87 M | - | -1.59 M | -14.3 M | -1.62 M | - | -577 K | -190 K | -3.64 M | - | -4.45 M | -4.47 M | -4.36 M | - | -3.74 M | -4.27 M | -5.03 M | - | -4.16 M | -5.04 M | -4.46 M | - | -3.85 M | -3.57 M | -3.19 M | - | -2.19 M | -1.79 M | -1.28 M | - | -429 K | -247 K | -2.31 K | -2.78 K | -8.15 K | -1.55 K | -95.4 K | -1.3 K | -5.94 K | -1.05 K | -1.3 K |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | -431 K | - | 7 K | 12 K | 10 K | - | 20 K | 34 K | 29 K | - | -148 K | 5 K | 1 K | - | 16 K | 1 K | 1 K | - | -436 K | -436 K | -436 K | - | 25 K | 25 K | 25 K | - | 22 K | 13 K | 6 K | - | - | - | - | - | - | - | - |
EBITDA |
- | -4 M | - | -3.12 M | -9.4 M | -3.14 M | - | -3 M | -2.97 M | -1.87 M | - | -1.59 M | -14.3 M | -1.62 M | - | -577 K | -190 K | -3.63 M | - | -4.4 M | -4.43 M | -4.35 M | - | -3.74 M | -4.25 M | -5.02 M | - | -4.11 M | -5 M | -4.44 M | - | -3.81 M | -3.55 M | -3.18 M | - | -2.19 M | -1.79 M | -1.28 M | - | -423 K | -243 K | -1.31 K | -2.73 K | -8 K | -1.45 K | -94.9 K | -1.25 K | -5.78 K | -1 K | -1.25 K |
Operating Expenses |
4 M | 4 M | - | 3.13 M | 9.4 M | 3.22 M | - | 3.27 M | 3.36 M | 1.91 M | - | 1.92 M | 14.3 M | 1.62 M | - | 795 K | 190 K | 3.64 M | - | 4.4 M | 4.48 M | 4.37 M | - | 3.74 M | 4.28 M | 5.04 M | - | 4.17 M | 5.04 M | 4.47 M | - | 3.85 M | 3.57 M | 3.18 M | - | 2.19 M | 1.79 M | 1.28 M | - | 429 K | 247 K | 103 K | 2.78 K | 8.16 K | 1.55 K | 95.4 K | 1.3 K | 5.94 K | 1.05 K | 1.3 K |
General and Administrative Expenses |
1.37 M | 1.63 M | - | 1.34 M | 1.51 M | 1.7 M | - | 1.3 M | 1.56 M | 1.07 M | - | 1.23 M | 1.06 M | 1.38 M | - | 1.24 M | 1.12 M | 1.18 M | - | 1.62 M | 1.18 M | 1.45 M | - | 1.09 M | 1.28 M | 1.3 M | - | 1.15 M | 1.17 M | 1.19 M | - | 930 K | 1.12 M | 1.03 M | - | 753 K | 732 K | 531 K | - | 160 K | 87 K | 59 K | 781 | 155 | 52 | 4.18 K | 51 | 2.44 K | 3 | 51 |
All numbers in USD currency